X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1508) 1508
Book Chapter (10) 10
Newspaper Article (10) 10
Magazine Article (4) 4
Conference Proceeding (1) 1
Government Document (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1073) 1073
humans (881) 881
platinum (819) 819
chemotherapy (690) 690
oncology (624) 624
cancer (623) 623
female (557) 557
ovarian cancer (439) 439
cisplatin (399) 399
deoxyribonucleic acid--dna (294) 294
tumors (271) 271
cancer therapies (259) 259
middle aged (259) 259
gene expression (249) 249
genetic aspects (231) 231
research (229) 229
survival (226) 226
patients (224) 224
mutation (222) 222
ovarian neoplasms - drug therapy (219) 219
prognosis (218) 218
dna repair (211) 211
aged (208) 208
platinum-based chemotherapy (207) 207
care and treatment (199) 199
male (193) 193
animals (191) 191
ovarian neoplasms - genetics (190) 190
lung cancer (189) 189
adult (186) 186
analysis (185) 185
dna (184) 184
antineoplastic agents - therapeutic use (182) 182
cell line, tumor (181) 181
expression (181) 181
antineoplastic agents - pharmacology (180) 180
proteins (179) 179
apoptosis (176) 176
dna damage (169) 169
breast cancer (167) 167
genes (167) 167
genomes (167) 167
multidisciplinary sciences (153) 153
medical prognosis (150) 150
ovarian neoplasms - pathology (145) 145
health aspects (144) 144
biochemistry & molecular biology (143) 143
cisplatin - pharmacology (143) 143
biomarkers (138) 138
metastasis (138) 138
carcinoma (134) 134
medicine (131) 131
cell biology (130) 130
drug resistance (130) 130
pharmacology & pharmacy (130) 130
resistance (130) 130
lung neoplasms - drug therapy (118) 118
clinical trials (117) 117
lung neoplasms - genetics (117) 117
research article (114) 114
ovarian carcinoma (113) 113
breast-cancer (111) 111
genomics (111) 111
drug resistance, neoplasm - genetics (110) 110
science (110) 110
carboplatin (107) 107
cytotoxicity (107) 107
toxicity (107) 107
treatment outcome (106) 106
antineoplastic combined chemotherapy protocols - therapeutic use (103) 103
studies (101) 101
drug resistance, neoplasm (99) 99
drug therapy (98) 98
metastases (97) 97
homologous recombination (96) 96
cell cycle (95) 95
genetics & heredity (93) 93
carcinoma, non-small-cell lung - drug therapy (91) 91
poly polymerase (91) 91
carcinoma, non-small-cell lung - genetics (90) 90
disease-free survival (90) 90
endocrine system diseases (90) 90
kinases (90) 90
medical research (90) 90
cell lung-cancer (89) 89
hematology, oncology and palliative medicine (89) 89
mice (88) 88
surgery (88) 88
polymorphism, single nucleotide (87) 87
aged, 80 and over (85) 85
dna methylation (85) 85
neoplasm staging (83) 83
survival analysis (83) 83
biology (81) 81
dna-repair (80) 80
genetics (80) 80
antineoplastic agents (78) 78
medicine & public health (78) 78
development and progression (77) 77
chemistry, multidisciplinary (75) 75
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Waddell, Nicola and Pajic, Marina and Patch, Ann-Marie and Chang, David K and Kassahn, Karin S and Bailey, Peter and Johns, Amber L and Miller, David and Nones, Katia and Quek, Kelly and Quinn, Michael C. J and Robertson, Alan J and Fadlullah, Muhammad Z. H and Bruxner, Tim J. C and Christ, Angelika N and Harliwong, Ivon and Idrisoglu, Senel and Manning, Suzanne and Nourse, Craig and Nourbakhsh, Ehsan and Wani, Shivangi and Wilson, Peter J and Markham, Emma and Cloonan, Nicole and Anderson, Matthew J and Fink, J. Lynn and Holmes, Oliver and Kazakoff, Stephen H and Leonard, Conrad and Newell, Felicity and Poudel, Barsha and Song, Sarah and Taylor, Darrin and Waddell, Nick and Wood, Scott and Xu, Qinying and Wu, Jianmin and Pinese, Mark and Cowley, Mark J and Lee, Hong C and Jones, Marc D and Nagrial, Adnan M and Humphris, Jeremy and Chantrill, Lorraine A and Chin, Venessa and Steinmann, Angela M and Mawson, Amanda and Humphrey, Emily S and Colvin, Emily K and Chou, Angela and Scarlett, Christopher J and Pinho, Andreia V and Giry-Laterriere, Marc and Rooman, Ilse and Samra, Jaswinder S and Kench, James G and Pettitt, Jessica A and Merrett, Neil D and Toon, Christopher and Epari, Krishna and Nguyen, Nam Q and Barbour, Andrew and Zeps, Nikolajs and Jamieson, Nigel B and Graham, Janet S and Niclou, Simone P and Bjerkvig, Rolf and Grützmann, Robert and Aust, Daniela and Hruban, Ralph H and Maitra, Anirban and Iacobuzio-Donahue, Christine A and Wolfgang, Christopher L and Morgan, Richard A and Lawlor, Rita T and Corbo, Vincenzo and Bassi, Claudio and Falconi, Massimo and Zamboni, Giuseppe and Tortora, Giampaolo and Tempero, Margaret A and Gill, Anthony J and Eshleman, James R and Pilarsky, Christian and Scarpa, Aldo and Musgrove, Elizabeth A and Pearson, John V and Biankin, Andrew V and Grimmond, Sean M and Australian Pancreatic Canc Genome and Australian Pancreatic Cancer Genome Initiative
Nature, ISSN 0028-0836, 02/2015, Volume 518, Issue 7540, pp. 495 - 501
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 05/2011, Volume 103, Issue 10, pp. 817 - 825
...). Methods To identify genetic variants associated with poor overall survival in these patients, we conducted a genome-wide scan of 307 260 single-nucleotide polymorphisms (SNPs... 
BREAST-CANCER | DOMAIN | POLYMORPHISMS | CISPLATIN-INDUCED CYTOTOXICITY | CHEMERIN | ONCOLOGY | RECEPTOR FAMILY | RISK | GENETIC-VARIANTS | SUSCEPTIBILITY LOCUS | IDENTIFICATION | Smoking - adverse effects | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Multivariate Analysis | Area Under Curve | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - radiotherapy | Lung Neoplasms - pathology | Male | Organoplatinum Compounds - administration & dosage | Aged, 80 and over | Adult | Female | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Receptors, Chemokine - genetics | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Genome-Wide Association Study | Reproducibility of Results | Carcinoma, Non-Small-Cell Lung - genetics | Kaplan-Meier Estimate | Proportional Hazards Models | Genotype | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Linkage Disequilibrium | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Smoking - epidemiology | ROC Curve | Aged | Polymorphism, Single Nucleotide | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Chemotherapy | Care and treatment | Platinum | Patient outcomes | Genetic aspects | Diagnosis | Research | Lung cancer, Non-small cell | Health aspects | Cancer
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2017, Volume 23, Issue 19, pp. 5757 - 5768
Purpose: Our purpose was to characterize the clinical influences, genetic risk factors, and gene mechanisms contributing to persistent cisplatin-induced... 
CELL LUNG-CANCER | BREAST-CANCER | GENETIC POLYMORPHISMS | ONCOLOGY | TESTICULAR CANCER | MISMATCH REPAIR | TOXICITY | OVARIAN-CANCER | QUESTIONNAIRE | ASSOCIATION | CHEMOTHERAPY | Cancer Survivors | Peripheral Nervous System Diseases - chemically induced | Age Factors | Humans | Middle Aged | Male | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Testicular Neoplasms - complications | Cell Cycle Proteins - genetics | Adult | Peripheral Nervous System Diseases - pathology | Gene Expression Regulation, Neoplastic - drug effects | Hypertension - genetics | Neoplasm Proteins - genetics | Peripheral Nervous System Diseases - genetics | Genome-Wide Association Study | Testicular Neoplasms - genetics | Risk Factors | Genotype | Hypertension - pathology | Testicular Neoplasms - drug therapy | Adolescent | Age of Onset | Cisplatin - adverse effects | Hypertension - complications | Polymorphism, Single Nucleotide - genetics | Aged | Hypertension | Health | Diabetes mellitus | Genomes | Single-nucleotide polymorphism | Genetic diversity | Risk analysis | Gene expression | Peripheral neuropathy | Cisplatin | Risk factors | Body mass index | Hypercholesterolemia | Genotyping | Body mass | Experimental design | Body size | Quality control | Replication | Age | Cancer | Smoking | testicular cancer | Platinum Study | genome wide association study | young adult | cancer survivorship | cisplatin | peripheral neuropathy | germ cell tumor | patient reported outcomes | pharmacogenetics
Journal Article
Journal Article
PLANT BIOTECHNOLOGY, ISSN 1342-4580, 09/2019, Volume 36, Issue 3, pp. 167 - 173
.... Recently, genome-editing technologies using artificial site-specific nucleases such as TALEN and CRISPR-Cas9 have been developed and used in plant sciences... 
genome editing | MUTAGENESIS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | potato | TALEN | TETRAPLOID POTATO | BIOSYNTHESIS | CONSTRUCTION | GENES | steroidal glycoalkaloids | EXPRESSION | PLANT SCIENCES | CRISPR | Plants (botany) | Phenotypes | Transformation | Potatoes | Toxicity | Breeding | Crops | Editing | Glycoalkaloids | Genomes | Biosynthesis | Gene expression | Mutants | Gene sequencing | Metabolites | Platinum | Original Paper
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2013, Volume 131, Issue 1, pp. 8 - 14
Journal Article
Journal Article